NCT00537602View on ClinicalTrials.gov

Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions

Cystic Fibrosis

Interventions

DRUG

miglustat

DRUG

placebo

Trial Locations (1)

Unknown

Corporacio Parc Tauli / Parc Tauli Hospital, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Actelion

INDUSTRY

NCT00537602 - Miglustat / OGT 918 in the Treatment of Cystic Fibrosis | Biotech Hunter | Biotech Hunter